THE ATLANTA VOICE – While pandemic associated medical care delays and avoidance may be understandable, safely returning to essential care is imperative for improving patient outcomes and reducing disparities as well as increasing patient access and ability to participate in clinical research.
The post Why clinical trial diversity is key to increasing access to routine care and innovative treatment first appeared on BlackPressUSA.
